Search This Blog

Monday, August 5, 2019

Harpoon Therapeutics EPS beats by $0.16, misses on revenue

Harpoon Therapeutics (NASDAQ:HARP): Q2 GAAP EPS of -$0.49 beats by $0.16.
Revenue of $1.06M (flat Y/Y) misses by $0.13M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)